Skip to content
0%

Calico

  • Research & Technology
    • Research & Technology
    • Publications
  • Drug Development
    • Drug Development
    • Clinical Trials
  • Partnering
  • Leadership
  • Careers
    • Job Openings
    • PostDoc Program
  • Mission and Values
  • Leadership
  • Research & Technology
  • Drug Development
  • Patients
  • Partnering
  • Collaborator Profiles
  • People
  • Publications
  • News & Media
    • Press Releases
    • Calico Stories
  • Life at Calico
  • Careers
    • Job Openings
    • PostDoc Program
  • Contact Us
Back to Publications
Publications

A Single-Step, High-Dose Selection Scheme Reveals Distinct Mechanisms of Acquired Resistance to Oncogenic Kinase Inhibition in Cancer Cells

Kenneth J. Finn, Scott E. Martin and Jeff Settleman
Cancer Research January 1, 2020
See Full Publication Back to Publications
About Us
  • Research & Technology
  • Drug Development
  • Leadership
  • Partnering
  • Life at Calico
Resources
  • Publications
  • Calico Stories
  • News & Media
  • Patients
Contact Us
  • Contact Us
  • Join Us
Follow Us
  • X
  • LinkedIn
  • Privacy Policy
  • Notice at Collection
  • Terms of Use
  • Code of Conduct
2025 Calico Life Sciences LLC. All rights reserved.